Molgramostim biosimilar (Amega Biotech)

莫拉司亭生物类似药（Amega Biotech）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMolgramostim biosimilar (Amega Biotech)

Drug Alias Name莫拉司亭生物仿制药（Amega Biotech）rhGM-CSF (Amega Biotech)Recombinant GM-CSF (Amega Biotech)Molgramostim follow-on biologic (Amega Biotech)Recombinant human granulocyte macrophage colony stimulating factor (Amega Biotech)

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants

TargetsGranulocyte-macrophage colony-stimulating factor receptor

Therapy Area/IndicationsNeutropeniaLeukopenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesAmega Biotech

China Registration ClassN/A

Develop Information

Active CompaniesAmega Biotech

Inactive CompaniesN/A

Active IndicationsNeutropeniaLeukopenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA03